<DOC>
	<DOCNO>NCT01901276</DOCNO>
	<brief_summary>The colonic microbiome essential human health disease . Clostridium difficile-associated diarrhea ( CDAD ) , highly morbid form infectious diarrhea , cause antibiotic perturb microbiome allow C. difficile proliferate . Proton pump inhibitor ( PPIs ) powerful suppressor gastric acid among common medicine United States . Dozens observational study show longterm PPI use associate CDAD . However , mechanism PPIs cause CDAD unknown . We believe PPIs cause CDAD induce alteration human colonic microbiome . We confirm refute hypothesize mechanism association PPIs CDAD use unblinded , single-armed study design . We use pyrosequencing hypervariable V4 region bacterial 16S ribosomal subunit gene human fecal sample describe colonic flora . We collect fecal sample volunteer PPIs give different duration test microbiome determine 1 ) whether PPIs diminish overall diversity , 2 ) whether PPIs diminish relative abundance Bacteroidetes , 3 ) whether increase duration PPIs affect diversity , 4 ) whether recovery diversity complete defined course PPIs . We believe PPIs cause pattern diminish overall microbiome diversity reduce anaerobes â€” pattern see use antibiotic . Furthermore , believe increase PPI duration diminish diversity microbiome return pre-PPI level diversity PPIs stop . These result facilitate biologically-based clinical intervention reduce rate CDAD among patient require acid suppression .</brief_summary>
	<brief_title>Effects Gastric Acid Colonic Microbiome</brief_title>
	<detailed_description>Study Design We recruit 12 adult volunteer crossover study total duration 12 week . Subjects observe PPIs 4 week place PPIs 4 week . Subsequently , subject randomize receive additional 4 week PPIs therapy . Stool sample collect 4 separate time point . Study Outcomes Statistical Analyses The primary outcome change overall diversity fecal flora 4 week PPIs compare 4 week acid suppression . Additional outcome assess include effect PPIs relative abundance Bacteroidetes week 4 change diversity fecal flora week 8 .</detailed_description>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>18 year old Able give inform consent Use systemic antibiotic within past year Use acid suppression medication ( PPIs H2receptor antagonist ) within past year ( antacid permit one month date enrollment ) History chronic gastrointestinal mucosal disease ( e.g . inflammatory bowel disease , celiac disease , microscopic colitis ) Any clinically significant uncontrolled major morbidity , include limited serious cardiac respiratory disease uncontrolled HIV Abnormal bowel frequency ( minimum every 2 day , maximum 3 time per day ) Use clopidogrel medication potential significant interaction PPIs Osteoperosis history nontraumatic bone fracture History adverse reaction PPIs Initiation new medication within month prior enrollment Pregnancy Inability give inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Proton Pump Inhibitors</keyword>
	<keyword>Microbiome</keyword>
	<keyword>Clostridium difficile</keyword>
</DOC>